These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. Voytko ML; Tinkler GP; Browne C; Tobin JR Am J Primatol; 2009 Sep; 71(9):794-801. PubMed ID: 19475542 [TBL] [Abstract][Full Text] [Related]
5. Lifelong endocrine fluctuations and related cognitive disorders. Ancelin ML; Ritchie K Curr Pharm Des; 2005; 11(32):4229-52. PubMed ID: 16375742 [TBL] [Abstract][Full Text] [Related]
6. Estrogens and memory in physiological and neuropathological conditions. Pompili A; Arnone B; Gasbarri A Psychoneuroendocrinology; 2012 Sep; 37(9):1379-96. PubMed ID: 22309827 [TBL] [Abstract][Full Text] [Related]
7. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones]. Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240 [TBL] [Abstract][Full Text] [Related]
9. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Sohrabji F Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752 [TBL] [Abstract][Full Text] [Related]
10. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. Zhao L; Brinton RD BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397 [TBL] [Abstract][Full Text] [Related]
11. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Lee SJ; McEwen BS Annu Rev Pharmacol Toxicol; 2001; 41():569-91. PubMed ID: 11264469 [TBL] [Abstract][Full Text] [Related]
15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
16. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Wise PM; Dubal DB; Wilson ME; Rau SW; Böttner M Endocrinology; 2001 Mar; 142(3):969-73. PubMed ID: 11181507 [TBL] [Abstract][Full Text] [Related]
19. Current perspectives on the benefits of HRT in menopausal women. Palacios S Maturitas; 1999 Nov; 33 Suppl 1():S1-13. PubMed ID: 10661610 [TBL] [Abstract][Full Text] [Related]